1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

  • July 2017
  • 40 pages
  • GlobalData
Report ID: 3389020

Summary

Table of Contents

Search Inside

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026

Summary
Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency (WHO, 2016a). T2D constitutes approximately 90-95% of all diabetes cases around the world while, type 1 diabetes (T1D) and gestational diabetes make up the remaining 5-10% of the cases (CDC, 2011; CDC, 2014b; IDF, 2014).

The prevalence of diabetes is expected to grow rapidly as it is associated with aging populations, increasing urbanization, economic development, and the increase in the prevalence of risk factors like obesity, unhealthy dietary habits, and physical inactivity (IDF, 2015). Globally, diabetes will likely be the seventh-leading cause of death in the world by 2030 (Mathers and Loncar, 2006). Additionally, poorly managed diabetes leads to serious complications such as heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage. Diabetes also increases the risk of fetal death and other complications during pregnancy (WHO, 2016b).

In the 7MM, our epidemiologists forecast an increase in the diagnosed prevalent cases of T2D from 56,060,328 diagnosed prevalent cases in 2016 to 77,823,223 diagnosed prevalent cases in 2026, with an annual growth rate (AGR) of 3.88% during the forecast period. The US will have the highest number of diagnosed prevalent cases of T2D among the 7MM throughout the forecast period, while Italy will have the lowest.

The report "EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026" provides an overview of the risk factors, comorbidities, and the global and historical trends for T2D in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) and also includes a 10-year epidemiological forecast for the diagnosed prevalent cases of T2D segmented by age (for ages 20 years and older) and sex in these markets. Additionally, the report provides a forecast of the major comorbidities of T2D, such as chronic kidney disease, cardiovascular disease, obesity, hypertension, and dyslipidemia in the diagnosed T2D prevalent pool.

Scope
- The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of T2D in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of T2D segmented by age (for ages 20 years and older) and sex in these markets. Additionally, the report provides a forecast of the major comorbidities of T2D, such as chronic kidney disease, cardiovascular disease, obesity, hypertension, and dyslipidemia in the diagnosed T2D prevalent pool.
- The T2D epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy
The T2D EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global T2D market.
- Quantify patient populations in the global T2D market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for T2D therapeutics in each of the markets covered.
- Identify the percentage of T2D diagnosed prevalent cases by age, sex, and major comorbid disorders.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Diabetic Nephropathy Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Diabetic Nephropathy Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic ...

Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic ...

Diabetic Foot Ulcers Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Diabetic Foot Ulcers Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Diabetic Foot Ulcers Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.